Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Neoadjuvant Chemotherapy|DRUG: postoperative chemotherapy
Sponsor: Chinese Academy of Medical Sciences